Bufuralol, dextromethorphan, and debrisoquine as prototype substrates for human P450IID6.
T
T
Kronbach
D000319:Adrenergic beta-Antagonists / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D019389:Cytochrome P-450 CYP2D6; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D003647:Debrisoquin / Q000378:metabolism*; D003915:Dextromethorphan / Q000378:metabolism*; D004983:Ethanolamines / Q000378:metabolism*; D006801:Humans; D008862:Microsomes, Liver / Q000201:enzymology*; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D013050:Spectrometry, Fluorescence / Q000379:methods; D013379:Substrate Specificity
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D003915:Dextromethorphan; C010831:bufuralol; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D019389:Cytochrome P-450 CYP2D6; D003647:Debrisoquin